Leaders from Gushan Town, Yongkang City and local elites from Gushan visited Xingyue Biotechnology for inspection and exchange on developing new quality productivity and deepening innovation in the biological industry
Inspection Overview
On the afternoon of May 15th, Hu Jirong, President of the Xiangxian Association and President of China Xingyue Group in Gushan Town, Yongkang City, aimed to stimulate innovation vitality and develop new quality productivity; Hu Xiaobin, Mayor of Gushan Town; Zhu Youkang, Executive Vice Chairman of the Xiangxian Association and former Vice Chairman of the Yongkang Municipal Political Consultative Conference; Hu Tingting, Vice President of Xingyue Group, and Li Wenshuai, Chairman of Gushan Town People's Congress, visited Xingyue Biotechnology for inspection and exchange. Xuan Tiefeng, General Manager of Xingyue Biotechnology, Zhao Hongshi, Executive Vice General Manager, Chen Longkun, Deputy General Manager, and Yu Jinyou, Office Director, accompanied the inspection.
Accompanied by company personnel, the inspection team first visited the Hangzhou Future Science and Technology City Planning Exhibition Hall. Hangzhou Future Science and Technology City is a high-end talent gathering area in Zhejiang Province and a source of future science and technology in Yuhang District. Through multimedia interactive displays and comprehensive explanations by staff, the inspection team gained a detailed understanding of the development history, industrial trends, innovation and entrepreneurship, ecological construction and other achievements of the Future Science and Technology City. Subsequently, the inspection team visited the Xingyue Science and Technology Innovation Industrial Park and visited areas such as Xingyue Biotechnology GMP Purification Workshop, R&D Center, Intellectual Property Exhibition Wall, Product Exhibition Hall, and Corporate Culture Wall. They learned about Xingyue Biotechnology's development layout in the new materials industry chain, especially its research and development achievements and core advantages in the field of biomedicine, and had in-depth exchanges on how to develop new quality productivity.
At the exchange meeting, Zhao Hongshi, Executive Vice General Manager of Xingyue Biotechnology, warmly welcomed the arrival of the inspection team and introduced the company's development history, main products, research and development achievements, industrial chain cultivation, and future development plans to the inspection team. Xingyue Biotechnology has been focusing on the research and development of medical silk materials for 19 years. Currently, it has applied for 38 patents related to biomaterials, of which 20 invention patents have been authorized, including 1 international patent; Complete the registration of 5 main documents for medical device raw materials; Participated in drafting multiple industry standards, international standards, and group standards.
Hu Jirong, President of Gushan Town Xiangxian Association and President of Xingyue Group, stated that current technological innovation is facing the problem of key technology bottlenecks, and promoting the development of new quality productivity will inject new impetus into high-quality development. As a subsidiary of Xingyue Group, Xingyue Biotechnology has always focused on medical silk research, attached great importance to investment in scientific and technological innovation, laid out the field of biomaterials, and achieved a series of significant results. At the same time, it emphasizes that Xingyue Biotechnology should actively consolidate its industry foundation and deeply cultivate product innovation.
Zhu Youkang, Executive Vice Chairman of Gushan Town Xiangxian Association and former Vice Chairman of Yongkang Municipal Political Consultative Conference, stated that the theme of this inspection is to develop new quality productive forces, learn from advanced technology, broaden horizons, explore the reshaping and reconstruction of the industrial system, and promote high-tech, high-efficiency, and high-quality development. Xingyue Biotechnology is a platform based enterprise in the entire biotechnology industry chain, and its development in recent years is evident. Relying on its technological advantages, it has connected the industry university research cooperation chain, actively promoted the transformation of scientific research achievements, and achieved remarkable results. In the future, it can further exchange and cooperate.
As a leader in the silk fibroin industry, Xingyue Biotechnology has always focused on the research of medical silk, leading industry changes with silk technology, achieving innovation and industry integration, and successfully making silk materials go beyond the laboratory and become products in the production line circulation market. Starry Moon Biotechnology has multiple brands under its umbrella, including Silk Rui Skin, Silk Rui Tai, Silk An Yan, etc., with "silk fibroin protein" as the core, specializing in various fields such as sports medicine and regenerative medicine, medical aesthetics, functional skincare, etc. In the future, Starry Moon Biotechnology will take "developing new quality productivity" as the starting point, based on the current development status of the enterprise, looking forward to industry trends, innovating research and development technologies, adhering to craftsmanship and intelligent manufacturing, and accumulating momentum and empowerment for promoting the industrialization of new materials.
